AI-based identification of patients who benefit from revascularization: a multicenter study
Zhang, W.; Miller, R. J.; Patel, K.; Shanbhag, A.; Liang, J.; Lemley, M.; Ramirez, G.; Builoff, V.; Yi, J.; Zhou, J.; Kavanagh, P.; Acampa, W.; Bateman, T. M.; Di Carli, M. F.; Dorbala, S.; Einstein, A. J.; Fish, M. B.; Hauser, M. T.; Ruddy, T.; Kaufmann, P. A.; Miller, E. J.; Sharir, T.; Martins, M.; Halcox, J.; Chareonthaitawee, P.; Dey, D.; Berman, D.; Slomka, P.
Show abstract
Background and AimsRevascularization in stable coronary artery disease often relies on ischemia severity, but we introduce an AI-driven approach that uses clinical and imaging data to estimate individualized treatment effects and guide personalized decisions. MethodsUsing a large, international registry from 13 centers, we developed an AI model to estimate individual treatment effects by simulating outcomes under alternative therapeutic strategies. The model was trained on an internal cohort constructed using 1:1 propensity score matching to emulate randomized controlled trials (RCTs), creating balanced patient pairs in which only the treatment strategy--early revascularization (defined as any procedure within 90 days of MPI) versus medical therapy--differed. This design allowed the model to estimate individualized treatment effects, forming the basis for counterfactual reasoning at the patient level. We then derived the AI-REVASC score, which quantifies the potential benefit, for each patient, of early revascularization. The score was validated in the held-out testing cohort using Cox regression. ResultsOf 45,252 patients, 19,935 (44.1%) were female, median age 65 (IQR: 57-73). During a median follow-up of 3.6 years (IQR: 2.7-4.9), 4,323 (9.6%) experienced MI or death. The AI model identified a group (n=1,335, 5.9%) that benefits from early revascularization with a propensity-adjusted hazard ratio of 0.50 (95% CI: 0.25-1.00). Patients identified for early revascularization had higher prevalence of hypertension, diabetes, dyslipidemia, and lower LVEF. ConclusionsThis study pioneers a scalable, data-driven approach that emulates randomized trials using retrospective data. The AI-REVASC score enables precision revascularization decisions where guidelines and RCTs fall short. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/25329295v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@6e63d9org.highwire.dtl.DTLVardef@15d4f45org.highwire.dtl.DTLVardef@ff4805org.highwire.dtl.DTLVardef@1d15f8c_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- International Evaluation Of An Artificial Intelligence-Powered Ecg Model Detecting Occlusion Myocardial Infarction 95%
- Development and Multinational Validation of an Ensemble Deep Learning Algorithm for Detecting and Predicting Structural Heart Disease Using Noisy Single-lead Electrocardiograms 95%
- Simple Models Versus Deep Learning in Detecting Low Ejection Fraction From The Electrocardiogram 94%
Similar papers in this journal
- High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomised controlled trial 93%
- Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study 93%
- Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection Fraction 92%
Similar papers in this journal
- Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials 95%
- The HeartMagic prospective observational study protocol - characterizing subtypes of heart failure with preserved ejection fraction 94%
- Artificial intelligence of arterial Doppler waveforms to predict major adverse outcomes among patients evaluated for peripheral artery disease 94%
Similar papers in this journal
- Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study 92%
- Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services 92%
- Algorithm for Predicting Valvular Heart Disease from Heart Sounds in an Unselected Cohort 92%
Similar papers in this journal
- Automated severe aortic stenosis detection on single-view echocardiography: A multi-center deep learning study 94%
- Mortality Risk and Treatment Disparities in the Chinese SMuRF-less STEMI Patients: A Nationwide Cohort Study 93%
- AORTA Gene: Polygenic prediction improves detection of thoracic aortic aneurysm 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.